enhertu - fam - trastuzumab deruxtecan - nxki injection, powder, lyophilized, for solution
(Fam-Trastuzumab Deruxtecan-Nxki)Daiichi Sankyo Inc.
Usage: ENHERTU is indicated for the treatment of adult patients with HER2-positive metastatic breast cancer, HER2-low metastatic breast cancer, HER2-mutant non-small cell lung cancer, advanced HER2-positive gastric cancer, and HER2-positive solid tumors. It is used as monotherapy or in combination, depending on prior treatments and disease progression.